Cellectis S.A. (CLLS)
NASDAQ: CLLS · Real-Time Price · USD
2.600
-0.060 (-2.26%)
At close: Aug 8, 2025, 4:00 PM
2.680
+0.080 (3.08%)
After-hours: Aug 8, 2025, 6:50 PM EDT
Cellectis Revenue
Cellectis had revenue of $18.19M in the quarter ending June 30, 2025, with 91.46% growth. This brings the company's revenue in the last twelve months to $63.44M, up 223.09% year-over-year. In the year 2024, Cellectis had annual revenue of $49.22M with 435.37% growth.
Revenue (ttm)
$63.44M
Revenue Growth
+223.09%
P/S Ratio
3.15
Revenue / Employee
$285,757
Employees
222
Market Cap
199.97M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 49.22M | 40.02M | 435.37% |
Dec 31, 2023 | 9.19M | -16.53M | -64.26% |
Dec 31, 2022 | 25.72M | -12.87M | -33.35% |
Dec 31, 2021 | 38.60M | -20.97M | -35.20% |
Dec 31, 2020 | 59.56M | 36.57M | 159.09% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CLLS News
- 4 days ago - Cellectis S.A. (CLLS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Cellectis Reports Second Quarter 2025 Financial Results & Business Updates - GlobeNewsWire
- 12 days ago - Cellectis to Report Second Quarter 2025 Financial Results on August 4, 2025 - GlobeNewsWire
- 6 weeks ago - Cellectis Reports Results from Shareholders Meeting Held on June 26, 2025 - GlobeNewsWire
- 2 months ago - Cellectis' Annual Shareholders General Meeting to be Held on June 26, 2025 - GlobeNewsWire
- 3 months ago - Cellectis: Partnerships And Promised Data In 2025 Continue To Justify The Buy - Seeking Alpha
- 3 months ago - Cellectis Reports Financial Results for the First Quarter 2025 - GlobeNewsWire
- 3 months ago - Cellectis to Report First Quarter Financial Results on May 12, 2025 - GlobeNewsWire